TCRT Stock Analysis: Buy, Sell, or Hold?
TCRT - Alaunos Therapeutics, Inc. Common Stock
$2.30
0.04 (1.77%)
▲
5d:
+15.0%
30d:
-8.73%
90d:
-29.45%
HOLD
MODERATE Confidence
Analysis Updated: Jun 12, 2026 12:00 AM ET
Earnings: May 21, 2026
0d
Get Alerted When TCRT Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: TCRT shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
📊 HOLD: TCRT shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
In-depth Analysis How we analyze
Valuation Analysis: TCRT is currently trading at $2.30, which is considered slightly low relative to its 30-day fair value range of $2.22 to $2.75.
Technical Outlook: Technically, TCRT is in a downtrend. Immediate support is located at $1.96, while resistance sits at $3.09.
Market Sentiment: TCRT has a weak technical setup (25/100), with bearish trendlines and momentum suggesting caution for short-term entries. However, the stock is trading significantly above the average Wall Street target of $1.75. The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, TCRT is in a downtrend. Immediate support is located at $1.96, while resistance sits at $3.09.
Market Sentiment: TCRT has a weak technical setup (25/100), with bearish trendlines and momentum suggesting caution for short-term entries. However, the stock is trading significantly above the average Wall Street target of $1.75. The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
SLIGHTLY LOW
Historical Trading Range
$2.22 -
$2.75
Company Quality Score
41/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
47.4%
All Signals
- BULLISH: Price oversold vs 30-day range
- BEARISH: Weak technical setup (25/100)
- BULLISH: High volume confirmation
- BEARISH: Trading 22.6% above Wall St target ($1.75)
Trading Range Analysis
30-Day Trading Range
$2.22 -
$2.75
Current vs Trading Range
SLIGHTLY LOW
Support & Resistance Levels
Support Level
$1.96
Resistance Level
$3.09
Current Trend
Downtrend
Technical data as of
Jun 9, 2026
Fundamental Context
Forward P/E (Next Year Est.)
18.48
Wall Street Target
$1.75
(-22.6%)
Revenue Growth (YoY)
-25.0%
Share & Embed Analysis
Last updated: June 15, 2026 12:00 PM ET
Data refreshes hourly during market hours. Next update: 1:00 PM
Data refreshes hourly during market hours. Next update: 1:00 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is TCRT showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
BMRN
Biomarin Pharmaceutical … |
STRONG BUY
29 analysts |
$88 | 63 BUY |
|
IONS
Ionis Pharmaceuticals Inc |
BUY
26 analysts |
$102 | 58 HOLD |
|
CYTK
Cytokinetics Inc |
STRONG BUY
21 analysts |
$105 | 56 HOLD |
|
MRUS
Merus BV |
STRONG BUY
17 analysts |
$97 | 55 HOLD |
|
NRIX
Nurix Therapeutics Inc |
STRONG BUY
18 analysts |
$31 | 58 HOLD |
